Browsing Tag: Heart Failure With Reduced Ejection Fraction

HLS Therapeutics Partners with Bayer to Commercialize Verquvo in Canada HLS Therapeutics has entered into an agreement with Bayer to commercialize Verquvo (vericiguat) in Canada, marking HLS’s entry i...